Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4277935
Max Phase: Preclinical
Molecular Formula: C16H11ClN2O3S
Molecular Weight: 346.80
Molecule Type: Small molecule
Associated Items:
ID: ALA4277935
Max Phase: Preclinical
Molecular Formula: C16H11ClN2O3S
Molecular Weight: 346.80
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=c1cc(Sc2cccc(-c3ccc(Cl)cc3)c2)[nH]c(=O)n1O
Standard InChI: InChI=1S/C16H11ClN2O3S/c17-12-6-4-10(5-7-12)11-2-1-3-13(8-11)23-14-9-15(20)19(22)16(21)18-14/h1-9,22H,(H,18,21)
Standard InChI Key: JWNGNXCNIMNVGU-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 346.80 | Molecular Weight (Monoisotopic): 346.0179 | AlogP: 3.25 | #Rotatable Bonds: 3 |
Polar Surface Area: 75.09 | Molecular Species: ACID | HBA: 5 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 5.52 | CX Basic pKa: | CX LogP: 3.81 | CX LogD: 2.04 |
Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.56 | Np Likeness Score: -0.67 |
1. Wang L, Tang J, Huber AD, Casey MC, Kirby KA, Wilson DJ, Kankanala J, Xie J, Parniak MA, Sarafianos SG, Wang Z.. (2018) 6-Arylthio-3-hydroxypyrimidine-2,4-diones potently inhibited HIV reverse transcriptase-associated RNase H with antiviral activity., 156 [PMID:30031976] [10.1016/j.ejmech.2018.07.039] |
2. Wang L, Edwards TC, Sahani RL, Xie J, Aihara H, Geraghty RJ, Wang Z.. (2021) Metal binding 6-arylthio-3-hydroxypyrimidine-2,4-diones inhibited human cytomegalovirus by targeting the pUL89 endonuclease of the terminase complex., 222 [PMID:34147908] [10.1016/j.ejmech.2021.113640] |
Source(1):